JNCCN 360 - NSCLC - Ongoing CE Activities

Editor:

David S. Ettinger, MD, FACP, FCCP

Advertisement

Advertisement

Ongoing CE Activities

<em>KRAS</em> Mutations in NSCLC: Who, How, and When to Test

ALK- or ROS1-Rearranged NSCLC: Effectively Integrating Precision Medicine into Patient-Centered Care

Integrating the Latest Evidence Into KRAS Molecular Testing for NSCLC

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice

Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 1 of a 4-Part Series

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer

NCCN Pharmacy Updates: Updates on the Use of Immunotherapy & Targeted Therapy in NSCLC

Non-Small Cell Lung Cancer: Management of Patients With Resectable Disease

Tailoring Targeted Therapy: New Directions for Managing Patients Across the Spectrum of Non-Small Cell Lung Cancer

What’s on the Horizon for <em>KRAS</em>-Mutated NSCLC?

Sections

NCCN Resources

Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.